CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 220 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 4.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,869,389 | +15.9% | 105,318 | -5.4% | 0.01% | +25.0% |
| Q2 2023 | $2,475,869 | +22.9% | 111,275 | +19.6% | 0.00% | +33.3% |
| Q1 2023 | $2,014,467 | +3.1% | 93,004 | -3.3% | 0.00% | 0.0% |
| Q4 2022 | $1,954,309 | -21.0% | 96,224 | -0.3% | 0.00% | -25.0% |
| Q3 2022 | $2,475,000 | +6.5% | 96,514 | -1.2% | 0.00% | 0.0% |
| Q2 2022 | $2,323,000 | +3.8% | 97,689 | -1.7% | 0.00% | +33.3% |
| Q1 2022 | $2,238,000 | +10.9% | 99,394 | -2.5% | 0.00% | 0.0% |
| Q4 2021 | $2,018,000 | -8.9% | 101,895 | -9.5% | 0.00% | 0.0% |
| Q3 2021 | $2,215,000 | -11.6% | 112,531 | -1.2% | 0.00% | 0.0% |
| Q2 2021 | $2,505,000 | -13.4% | 113,876 | -6.4% | 0.00% | -25.0% |
| Q1 2021 | $2,894,000 | -11.2% | 121,646 | -2.4% | 0.00% | -20.0% |
| Q4 2020 | $3,260,000 | +3.5% | 124,648 | -31.2% | 0.01% | -16.7% |
| Q3 2020 | $3,151,000 | +15.7% | 181,064 | +11.8% | 0.01% | +20.0% |
| Q2 2020 | $2,724,000 | +13.1% | 161,964 | -20.1% | 0.01% | 0.0% |
| Q1 2020 | $2,409,000 | -5.1% | 202,620 | -3.4% | 0.01% | +25.0% |
| Q4 2019 | $2,538,000 | -7.0% | 209,698 | +8.6% | 0.00% | 0.0% |
| Q3 2019 | $2,729,000 | +28.3% | 193,181 | +1.3% | 0.00% | +33.3% |
| Q2 2019 | $2,127,000 | +2.9% | 190,728 | +8.3% | 0.00% | 0.0% |
| Q1 2019 | $2,067,000 | -10.6% | 176,071 | +1.8% | 0.00% | -25.0% |
| Q4 2018 | $2,312,000 | -5.8% | 173,024 | -1.1% | 0.00% | 0.0% |
| Q3 2018 | $2,454,000 | -16.6% | 175,023 | -6.5% | 0.00% | 0.0% |
| Q2 2018 | $2,943,000 | -58.4% | 187,213 | -56.4% | 0.00% | -63.6% |
| Q1 2018 | $7,071,000 | -76.9% | 429,873 | -74.6% | 0.01% | -73.8% |
| Q4 2017 | $30,615,000 | +43.9% | 1,695,163 | +53.8% | 0.04% | +35.5% |
| Q3 2017 | $21,278,000 | +184.8% | 1,102,483 | +74.1% | 0.03% | +181.8% |
| Q2 2017 | $7,472,000 | +3673.7% | 633,223 | +3409.5% | 0.01% | – |
| Q1 2017 | $198,000 | +40.4% | 18,043 | -16.6% | 0.00% | – |
| Q3 2016 | $141,000 | +60.2% | 21,643 | -8.0% | 0.00% | – |
| Q3 2015 | $88,000 | -37.6% | 23,513 | 0.0% | 0.00% | – |
| Q2 2015 | $141,000 | +327.3% | 23,513 | +100.4% | 0.00% | – |
| Q2 2014 | $33,000 | – | 11,734 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,340,193 | $227,229 | 10.94% |
| Novo Holdings A/S | 3,377,768 | $92,044,178 | 6.80% |
| Parallel Advisors, LLC | 3,723,483 | $101,446,294 | 3.38% |
| TANAKA CAPITAL MANAGEMENT INC | 37,569 | $1,024 | 2.92% |
| S&T BANK/PA | 334,252 | $9,107 | 1.76% |
| Birchview Capital, LP | 50,000 | $1,362,250 | 1.16% |
| Granite Investment Partners, LLC | 798,552 | $21,756,549 | 0.91% |
| FAS Wealth Partners, Inc. | 310,764 | $8,466,766 | 0.90% |
| Clearview Wealth Advisors LLC | 25,258 | $688,155 | 0.85% |
| Bridge City Capital, LLC | 43,485 | $1,184,749 | 0.60% |